» Articles » PMID: 35315420

Minimally Manipulated Adipose Derived Mesenchymal Stromal Cells and Osteoarthritis: A Narrative Review

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2022 Mar 22
PMID 35315420
Authors
Affiliations
Soon will be listed here.
Abstract

Human mesenchymal stromal cells (MSCs) have increasingly been used to treat osteoarthritis (OA) related pain and dysfunction, due to their capacity for regeneration and anti-inflammatory effects. Adipose-derived MSCs are characterized by their abundance, ease of access, easy isolation procedures, high lipoaspirate stromal cell production, quicker multiplication of cells, and less pain and morbidity during harvesting. These cells are typically enzymatically derived from adipose tissue but this technique has complicated regulatory problems. To address this problem, a new technique has been created to extract and process adipose tissue without expansion and the use of enzymes to produce autologous minimally manipulated adipose-derived MSCs. Recent studies have confirmed that this treatment is an effective and promising method for treating pain and improving joint function in patients affected by OA with a very low percentage of complications at short to mid-term follow-up.

Citing Articles

Research Guideline Recommendations for Research on Stem Cells, Human Embryos, and Gene Editing.

Var S, Strell P, Shetty A, Roman A, Clark I, Crane A Cell Transplant. 2025; 34:9636897241312793.

PMID: 40007211 PMC: 11863228. DOI: 10.1177/09636897241312793.


Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.

Wu K, Chang Y, Ding D, Lin S Int J Mol Sci. 2024; 25(23.

PMID: 39684619 PMC: 11641625. DOI: 10.3390/ijms252312911.


Clinical results in patients affected by moderate-severe knee osteoarthritis and treated with micro-fragmented adipose tissue: the therapeutic effects on symptomatology.

Zannoni F, Caravelli S, Russo A, Perisano C, Greco T, Baiardi A Musculoskelet Surg. 2024; 108(2):215-224.

PMID: 38602604 DOI: 10.1007/s12306-024-00816-2.


Schizophyllan promotes osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells in vitro.

Hemati S, Hatamian-Zarmi A, Halabian R, Ghiasi M, Salimi A Mol Biol Rep. 2023; 50(12):10037-10045.

PMID: 37902909 DOI: 10.1007/s11033-023-08877-5.


Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine.

Matsuzaka Y, Yashiro R Int J Mol Sci. 2022; 23(12).

PMID: 35742923 PMC: 9224400. DOI: 10.3390/ijms23126480.

References
1.
Panni A, Vasso M, Braile A, Toro G, De Cicco A, Viggiano D . Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response. Int Orthop. 2018; 43(1):7-13. DOI: 10.1007/s00264-018-4182-6. View

2.
Akkawi I . Ozone therapy for musculoskeletal disorders Current concepts. Acta Biomed. 2021; 91(4):e2020191. PMC: 7927499. DOI: 10.23750/abm.v91i4.8979. View

3.
Ceserani V, Ferri A, Berenzi A, Benetti A, Ciusani E, Pascucci L . Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells. Vasc Cell. 2016; 8:3. PMC: 4991117. DOI: 10.1186/s13221-016-0037-3. View

4.
Hudetz D, Boric I, Rod E, Jelec Z, Kunovac B, Polasek O . Early results of intra-articular micro-fragmented lipoaspirate treatment in patients with late stages knee osteoarthritis: a prospective study. Croat Med J. 2019; 60(3):227-236. PMC: 6563172. View

5.
Russo A, Screpis D, Di Donato S, Bonetti S, Piovan G, Zorzi C . Autologous micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis: an update at 3 year follow-up. J Exp Orthop. 2018; 5(1):52. PMC: 6300453. DOI: 10.1186/s40634-018-0169-x. View